MetaVia Inc (MTVA) Stock Analysis
Verdict: AVOID
High-tier drug pipeline for obesity is eclipsed by a severe cash runway crisis, making dilutive financing nearly certain by mid-2026.
Investment score: 38/100
Analysis as of
Is MetaVia Inc stock worth reviewing? AI model thesis
The model views MetaVia as a high-risk micro-cap with significant pipeline potential in obesity/MASH but critical financial instability. While the pipeline is reaching key milestones, the current cash levels are insufficient to reach the Q4 2026 readout without significant dilution or new debt.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 70/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
MetaVia Inc opportunities and risks
What speaks for MTVA
- Phase 1 Obesity Milestone Reached
What speaks against MTVA
- Imminent Dilutive Financing Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MTVA | n/a | 0.0x | 0.7x | 0.0% | 0.0% | -345.7% |
| MBRX | n/a | 0.0x | n/a | 0.0% | 0.0% | -205.9% |
| PHIO | n/a | 0.0x | 0.5x | 0.0% | 0.0% | -92.3% |
| BCLI | n/a | 0.0x | n/a | 0.0% | 0.0% | -57.5% |
| APUS | n/a | 0.0x | n/a | 0.0% | 0.0% | -1199.2% |
| TOVX | n/a | 27.8x | 0.1x | 92.0% | -7153.0% | -172.5% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -172.5% |
Frequently asked questions about MetaVia Inc (MTVA)
Is MTVA stock a good investment?
The cached TradeMates AI model rates MetaVia Inc as AVOID with an investment score of 38/100. The model views MetaVia as a high-risk micro-cap with significant pipeline potential in obesity/MASH but critical financial instability. While the pipeline is reaching key milestones, the current cash levels are insufficient to reach the Q4 2026 readout without significant dilution or new debt. This is algorithmic model output, not personal investment advice.
Is MTVA stock a buy?
The TradeMates model verdict for MTVA is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.